Author

Jens Frederik Dahlerup 1

1 Aarhus University Hospital,Department of Hepatology and Gastroenterology,Aarhus,Denmark

A QUESTIONNAIRE BASED SYMPTOM EVALUATION STUDY IN 381 PATIENTS DIAGNOSED WITH BILE ACID MALABSORPTION BY SEHCAT FROM 2003 TO 2016

Helene Rask Clausen, Brian Damsgaard, Jens Frederik Dahlerup, Jørgen Agnholt, Søren Peter Jørgensen, Klaus Krogh

CLINICAL TRIAL: HIGH-DOSE VITAMIN D TREATMENT TO CROHN'S DISEASE PATIENTS WITH DISEASE ACTIVITY, A RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLINDED STUDY (MIRVIDIC)

Mia Bendix, Anders Dige, Søren Peter Jørgensen, Jens Frederik Dahlerup, Bent Deleuran, Jørgen Agnholt

Course of indolent Crohn's disease in a prospective European population-based inception cohort with five years follow-up - the Epi-IBD cohort

Johan Burisch, Adrian Goldis, Linda Kievit, Doron Schwartz, Kari Rubek Nielsen, Naila Arebi, Mathurin Fumery, Limas Kupcinskas, Jens Frederik Dahlerup, Elena Belousova, Pia Oksanen, Vicent Hernández, Ebbe Langholz, Svetlana Turcan, Daniela Valpiani, Martina Giannotta, Fernando Magro, Dana Duricova, Riina Salupere, Ioanni

DIETARY INTERVENTION WITH A DIET RICH IN ARABINOXYLANS AND RESISTANT STARCH MODULATES T-CELL ACTIVATION ESTIMATED BY CD25 EXPRESSION IN METABOLIC SYNDROME

Stine Hald, Anders Kirch Dige, Sidsel Stoy, Mia Bendix, Anne Grethe Schioldan, Kjeld Hermansen, Søren Gregersen, Knud Erik Bach Knudsen, Jørgen Agnholt, Jens Frederik Dahlerup, Anders Dige

DISCONTINUATION OF INFLIXIMAB THERAPY IN PATIENTS WITH CROHN’S DISEASE IN SUSTAINED, COMBINED CLINICAL-BIOCHEMICAL-ENDOSCOPIC REMISSION: A DOUBLE-BLINDED, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL

Sine Buhl, Casper Steenholdt, Jens Frederik Dahlerup, Tobias Wirenfeldt Klausen, Mark Andrew Ainsworth, Jørgen Jahnsen, Jørn Brynskov, Ole Østergaard Thomsen, Katrine Risager Christensen, Akbar Molazahi, Natalia Pedersen, Niels Thorsgaard, Eva Efsen Dahl, Ida Vind, Hendrika Adriana Linda Kievit, Taina Sipponen, Jan Marsal;;

HIGH DOSE INTRAVENOUS IRON ISOMALTOSIDE IN PATIENTS WITH GASTROINTESTINAL DISEASES

Richard Derman, Jens Frederik Dahlerup, Walter Reinisch

HIGH DOSE ORAL THIAMINE REDUCES CHRONIC FATIGUE IN PATIENTS WITH QUIESCENT INFLAMMATORY BOWEL DISEASE: A RANDOMISED DOUBLE BLINDED CROSSOVER TRIAL

Palle Bager, Christian Lodberg Hvas, Charlotte Rud, Jens Frederik Dahlerup

INCIDENCE AND DISEASE PRESENTATION OF ELDERLY-ONSET IBD IN A EUROPEAN POPULATION-BASED INCEPTION COHORT - AN ANALYSIS OF THE EPI-IBD 2010-2011 COHORTS

Vicent Hernández Ramírez, Jesus Martinez Cadilla, Shaji Sebastian, IOANNIS (JOHN) KAIMAKLIOTIS, Silvija Cukovic Cavka, Jens Frederik Dahlerup, Karin Ladefoged, Limas Kupcinskas, Svetlana Turcan, Natalia Pedersen, Ebbe Langholz, Niels Thorsgaard, Vibeke Andersen, Riina Salupere, Elena Belousova, Konstantinos H. Katsanos, Olg

IS THERE A COST-SAVING EFFECT OF BIOLOGICAL THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE? RESULTS FROM A PROSPECTIVE EUROPEAN POPULATION-BASED INCEPTION COHORT

Johan Burisch, Hillel Vardi, Doron Schwartz, Naila Arebi, Peter L Lakatos, Mathurin Fumery, Limas Kupcinskas, Elena Belousova, Pia Oksanen, Vicent Hernández Ramírez, Ebbe Langholz, Zsuzsanna Vegh, Svetlana Turcan, Daniela Valpiani, Martina Giannotta, Fernando Jose Magro Dias, Dana Duricova, Linda Kievit, Jens Frederik Dah

OUTCOMES OF CORONAVIRUS DISEASE 2019 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES AND THE INFLUENCE OF IBD-RELATED MEDICATIONS– A DANISH PROSPECTIVE POPULATION-BASED COHORT STUDY

Kent Haderslev, Marianne Kajbæk Vester-Andersen, Asser Mathiassen Oppfeldt, Anja Poulsen, Akbar Molazahi, Malte Rosager Hansen, Anders Bergh Lødrup, Natalia Pedersen, August Pilegaard Prahm, Lone Larsen, Henning Glerup, Mohamed Attauabi, Tine Jess, Abdel Wase, Torben Nathan, Anders Neumann, Jakob Benedict Seidelin, Christi

Item 1 - 10 / 23
1
2 3